Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance

Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance

Mass vaccination campaigns against COVID-19 affected more than 90% of the population in most developed countries. The new epidemiologic wave of COVID-19 has been ongoing since the end of 2021. It is caused by a virus variant B.1.1.529, also known as “Omicron” and its descendants. The effectiveness o...

Full description

Bibliographic Details
Main Authors: Andrey S. Shkoda, Vladimir A. Gushchin, Darya A. Ogarkova, Svetlana V. Stavitskaya, Olga E. Orlova, Nadezhda A. Kuznetsova, Elena N. Keruntu, Andrei A. Pochtovyi, Alexander V. Pukhov, Denis A. Kleymenov, Vasyli G. Krzhanovsky, Daria V. Vasina, Nataliya V. Shkuratova, Elena V. Shidlovskaya, Alexey L. Gorbunov, Daria D. Kustova, Evgeniya A. Mazurina, Sofya R. Kozlova, Alexandra V. Soboleva, Igor V. Grigoriev, Lyudmila L. Pankratyeva, Alina S. Odintsova, Elizaveta D. Belyaeva, Arina A. Bessonova, Lyudmila A. Vasilchenko, Igor P. Lupu, Ruslan R. Adgamov, Artem P. Tkachuk, Elizaveta A. Tokarskaya, Denis Y. Logunov, Alexander L. Gintsburg
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
vaccine
Sputnik V
Sputnik Light
VOC
Online Access:https://www.mdpi.com/2076-393X/10/6/938

Internet

https://www.mdpi.com/2076-393X/10/6/938

Similar Items